CBV (chemotherapy)

From WikiMD.org
Jump to navigation Jump to search

CBV (Chemotherapy)

CBV (pronounced as C-B-V), is a chemotherapy regimen used primarily in the treatment of Hodgkin's lymphoma. The acronym CBV stands for the three drugs that make up the regimen: Cyclophosphamide, Bleomycin, and Vinblastine.

Pronunciation

CBV is pronounced as "C-B-V", with each letter pronounced separately.

Etymology

The term CBV is an acronym derived from the initial letters of the three drugs used in the regimen: Cyclophosphamide, Bleomycin, and Vinblastine.

Related Terms

  • Cyclophosphamide: An immunosuppressive drug used most commonly in chemotherapy. It is a prodrug that is converted in the body to its active form.
  • Bleomycin: A medication used for the treatment of several types of cancer including Hodgkin's lymphoma, testicular cancer, and ovarian cancer.
  • Vinblastine: A chemotherapy medication used to treat a number of types of cancer including Hodgkin's lymphoma, non-small cell lung cancer, bladder cancer, brain cancer, and testicular cancer.

Usage

The CBV regimen is used primarily in the treatment of Hodgkin's lymphoma. It is a combination of three drugs: Cyclophosphamide, Bleomycin, and Vinblastine. Each of these drugs works in a different way to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing.

Side Effects

Like all chemotherapy regimens, CBV can have side effects. These can include nausea, vomiting, hair loss, and a decrease in blood cells which can lead to an increased risk of infection, bleeding problems, tiredness, and breathlessness.

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski